Original Research

Long-term safety and tolerability of saxagliptin add-on therapy in older patients (aged ≥65 years) with type 2 diabetes

Iqbal N, Allen E, Öhman P

Clinical Interventions in Aging 2014, 9:1479-1487

Published Date: 4 September 2014